Summary:
This study is being done to evaluate the safety and efficacy of an investigational drug administered subcutaneously in healthy subjects with a 10-year Framingham Risk Score of 10% or less.
Inclusion Criteria:
•Male or female between 18 and 80 years of age
•Framingham risk score of 10% or less (ie, individual at low risk for cardiovascular event)
Exclusion Criteria:
•History of coronary heart disease
•NYHA III or IV heart failure
•Uncontrolled cardiac arrhythmia
•Uncontrolled hypertension
•Diabetes mellitus (Type 1 diabetes, poorly controlled Type 2 diabetes)
•Uncontrolled hypothyroidism or hyperthyroidism
•Pregnant or breast-feeding
Qualified Participants May Receive:
The study drug as well as all research-related tests, procedures and visits will be provided at no cost to the subject and their insurance.
Additionally, the subject will receive $50 for each scheduled clinic visit completed. The subject will not be charged for parking while attending study visits.